CONDENSED INDOLE DERIVATIVE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, PHARMACEUTICAL COMPOSITION SHOWING ACTIVITY OF 5-$$$-RECEPTOR ANTAGONIST Russian patent published in 1998 - IPC

Abstract RU 2104279 C1

FIELD: heterocyclic compounds. SUBSTANCE: invention relates to heterocyclic compounds showing activity of 5-$$$-receptor antagonist. Product: condensed indole derivative of the formula (I): $$$ where X - O; A - $$$; $$$ - hydrogen; Y - NH; Z means group of the formula: $$$ where $$$ means hydrogen, $$$-alkyl, phenyl-$$$-alkyl or $$$ - $$$ where z = 2 or 3, and $$$ is taken from phenoxy and $$$ where $$$ and $$$ - hydrogen or $$$-alkyl, or its pharmaceutically acceptable salt and pharmaceutical composition showing activity of 5-$$$-receptor antagonist and containing compound of the formula (I) at effective amount. EFFECT: improved method of synthesis, enhanced effectiveness of composition. 4 cl, 2 tbl

Similar patents RU2104279C1

Title Year Author Number
HETEROCYCLIC COMPOUNDS AS ANTAGONISTS OF 5-HT RECEPTORS, METHOD OF SYNTHESIS, PHARMACEUTICAL COMPOSITION 1992
  • Frehnsis Dehvid King
  • Ljarami Mari Gaster
  • Kit Rajmond Malkholland
  • Shirli Katrin Rakhman
  • Pol' Adrian Viman
  • Gehret Dzhon Zangen
  • Kej Alison Uordl
  • Gordon Smit Bakster
  • Gaj Ehntoni Kennet
  • Al'Berto Khulio Kauman
RU2124512C1
6-(SUBSTITUTED METHYLENE)PENEMS, METHOD OF PREPARING THEREOF, INTERMEDIATE PRODUCTS, AND PHARMACEUTICAL COMPOSITION 1993
  • Najdzhel Dzhon Perrimen Brum
  • Frehnk Peter Kharrington
RU2133750C1
METHOD OF EPOXIDATION OF PROCHIRAL OLEFIN 1995
  • Bell Dehvid
  • Finnej Frantsiska
  • Attrill Robin Patrik
  • Miller Dehvid
  • Terner Dzhillian
RU2204562C2
ANTAGONISTS OF ENDOTHELIAL RECEPTORS, PHARMACEUTICAL COMPOSITION, METHOD OF SYNTHESIS, METHOD OF INHIBITION OF ENDOTHELIAL RECEPTORS 1992
  • Rassell Donovan Kaznz
  • Dzhon Dunkan Ehlliott
  • Marija Amparo Lago
  • Dzhek Dejl Liber
  • Kehtrin Ehlizabet Pejshoff
RU2125980C1
HETEROCYCLIC COMPOUND OR ITS TAUTOMERIC FORM AND/OR PHARMACEUTICALLY ACCEPTABLE SALT AND/OR PHARMACEUTICALLY ACCEPTABLE SOLVATE, PHARMACEUTICAL COMPOSITION DECREASING BLOOD GLUCOSE LEVEL, METHOD OF TREATMENT AND/OR PROPHYLAXIS OF HYPOGLYCEMIC PATIENTS 1993
  • Dehvid Khej
  • Dzhon Tomas Sajm
RU2134686C1
METHOD OF TREATMENT OF STATE WHERE 5HT-LIKE AGONIST, DERIVATIVE OF TETRAHYDROCARBAZOLE IS REQUIRED, METHOD OF ITS SYNTHESIS, PHARMACEUTICAL COMPOSITION SHOWING ACTIVITY OF AGONIST OF 5HT-LIKE RECEPTORS 1992
  • Frehnsis Dehvid King
  • Larami Mehri Gehster
  • Al'Berto Dzhulio Kaumann
  • Rodni Kristofer Jang
RU2137474C1
METHOD OF PREPARING AND/OR PURIFYING CLAVULANIC ACID OR PHARMACEUTICALLY ACCEPTABLE SALTS OR ESTERS THEREOF CLAVULANIC ACID SALT WITH AMINO ACID 1993
  • Majkl Allen Kuk[Gb]
  • Robert Bennett Uilkins[Gb]
RU2105768C1
BENZOPYRANS, PHARMACEUTICAL COMPOSITION BASED THEREON, AND METHOD OF MEDICAL TREATMENT 1995
  • Vaj Ngor Chan
  • Ehlen Kejt Ehnn Morgan
  • Mervin Tompson
  • Dzhon Morris Ehvans
RU2147581C1
METHOD OF SYNTHESIS OF CLAVULANIC ACID OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND ETHERS, CLAVULANIC ACID SALT WITH AMINE 1995
  • Majkl Allen Kuk[Gb]
  • Robert Bennett Uilkins[Gb]
RU2081121C1
METHOD OF PREPARING CLAVULANIC ACID OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS OR ESTERS 1995
  • Majkl Allen Kuk[Gb]
  • Robert Bennett Uilkins[Gb]
RU2088586C1

RU 2 104 279 C1

Authors

Lehrami Mehri Gaster[Gb]

Pol Adrian Vajman[Gb]

Dates

1998-02-10Published

1993-03-10Filed